Pseudovirus-Based Strategies for Understanding and Controlling Viral Infections
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Viral Pathogens".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 3905
Special Issue Editor
Interests: SARS-CoV-2; HIV-1; HPV; vaccine development; vaccine evaluation; immune response; neutralizing antibody; standardization of assay
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pseudoviruses have become indispensable tools in biomedical research, serving as vital surrogates for authentic viruses across multiple applications. In broad terms, these recombinant constructs are defined by their incorporation of foreign genetic material, regardless of whether they display exogenous surface proteins. This versatile category has application in understanding the infectivity mechanisms, gene therapy delivery systems, vaccine vector development, and diagnostic control materials for nucleic acid assays.
Despite significant progress in pseudovirus development for emerging pathogens, substantial technical challenges persist. Current limitations include a lack of universal construction strategies, persistent technical barriers for certain virus families (e.g., flaviviruses), and inconsistent standardization across research groups.
Hence, this Special Issue, titled “Pseudovirus-Based Strategies for Understanding and Controlling Viral Infections”, promotes studies that focus on advanced pseudovirus packaging strategies; their use in studies of virus life cycles; emerging applications in vaccines, therapeutics, and diagnostics; and any other fields related to pseudovirses.
Dr. Jianhui Nie
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pseudovirus
- infectivity
- neutralization
- antigenicity
- immunogenicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
